Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

Ads

You May Also Like

Immunocore Limited: Appoints Paul Fry as Chief Financial Officer

ABINGDON, OXON, United Kingdom, Oct. 12, 2016 (GLOBE NEWSWIRE) -- Immunocore Limited, a world-leading ...